Used primarily in the treatment of chronic heart failure, it functions as a neprilysin inhibitor when combined with valsartan. This combination helps in reducing the risk of cardiovascular death and hospitalization by enhancing the levels of beneficial peptides that degrade harmful substances in the body. It is particularly effective in patients with reduced ejection fraction, improving overall heart function and quality of life.